Rovazolac

DB16320InvestigationalSmall molecule

Rovazolac is under investigation in clinical trial NCT03175354 (A Study in Subjects With Moderate Atopic Dermatitis).

Chemical structure of Rovazolac
Formula / weight
C21H19F3N2O4S · 452.45 g/mol (avg)
Code names
ALX-101

Resolves to

Compound
UNIIW51K389XILCAS1454288-88-0ChEMBLCHEMBL4297218
Structure
InChIKeyZUMNJDGBYXHASJ-UHFFFAOYSA-NSMILESCCOC(=O)CN1N=C(C=C1C1=CC=C(C=C1)C1=CC(=CC=C1)S(C)(=O)=O)C(F)(F)F

What you can answer from here — as of April 23, 2025

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Rovazolac, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In